Alterity Therapeutics Ltd (ATHE) stock has risen 110.83% over the past week and gets a Bearish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.
InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.
Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .
What's Happening With ATHE Stock Today?
Alterity Therapeutics Ltd (ATHE) stock is trading at $2.53 as of 10:47 AM on Monday, Nov 16, a rise of $1.38, or 120% from the previous closing price of $1.15. Volume today is above average. So far 60,643,618 shares have traded compared to average volume of 81,029 shares. The stock has traded between $2.44 and $3.58 so far today.
To see the top 5 stocks in the Biotechnology industry click here.
More About Alterity Therapeutics Ltd
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434).
Click Here to get the full Stock Score Report on Alterity Therapeutics Ltd (ATHE) Stock.
